NCT00549744View on ClinicalTrials.gov

Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing

PHASE2CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

November 16, 2007

Primary Completion Date

August 27, 2008

Study Completion Date

August 27, 2008

Conditions

Asthma

Interventions

DRUG

GSK256066

Trial Locations (3)

6035

GSK Investigational Site, Wellington

6529

GSK Investigational Site, George

9301

GSK Investigational Site, Bloemfontein

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY